Cedrus LLC Pfizer Inc Transaction History

Cedrus LLC

$200 Billion
Q2 2024

A detailed history of Cedrus LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cedrus LLC holds 13,198 shares of PFE stock, worth $406,102. This represents 0.18% of its overall portfolio holdings.

Number of Shares

13,198

Previous 12,377 6.63%

Holding current value

$406,102

Previous $343 Million 7.52%

% of portfolio

0.18%

Previous 0.19%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	BUY	$25.26 - $29.6 $20,738 - $24,301	821 Added 6.63%	13,198 $369 Million
Q1 2024 Apr 15, 2024	BUY	$25.89 - $29.73 $133,540 - $153,347	5,158 Added 71.45%	12,377 $343 Million
Q4 2023 Jan 26, 2024	SELL	$26.13 - $33.94 $38,750 - $50,333	-1,483 Reduced 17.04%	7,219 $208 Million
Q3 2023 Jan 24, 2024	SELL	$32.09 - $37.51 $1,123 - $1,312	-35 Reduced 0.4%	8,702 $289 Million
Q2 2023 Jan 24, 2024	SELL	$36.12 - $41.79 $16,326 - $18,889	-452 Reduced 4.92%	8,737 $320 Million

Q1 2023 Jan 24, 2024	BUY	$39.39 - $51.28 $46,952 - $61,125	1,192 Added 14.91%	9,189 $375 Million
Q4 2022 Jan 19, 2024	BUY	$41.75 - $54.5 $48,346 - $63,111	1,158 Added 16.93%	7,997 $410 Million
Q3 2022 Jan 19, 2024	BUY	$43.76 - $53.42 $29,012 - $35,417	663 Added 10.74%	6,839 $299 Million
Q2 2022 Jan 19, 2024	BUY	$46.53 - $55.17 $20,100 - $23,833	432 Added 7.52%	6,176 $324 Million
Q1 2022 Jan 19, 2024	SELL	$45.75 - $56.69 $65,605 - $81,293	-1,434 Reduced 19.98%	5,744 $297 Million
Q4 2021 Jan 19, 2024	BUY	$41.32 - $61.25 $296,594 - $439,652	7,178 New	7,178 $424 Million

Others Institutions Holding PFE

# of Institutions

3,167

Shares Held

3.66B

Call Options Held

67.5M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $173B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedrus LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedrus LLC with notifications on news.

Account